Associated Papers
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Perera SD et al.
Current Opinion in Lipidology, 2024
Nomogram developed with APOA5 genetic variant rs662799 and clinical characteristics predicting risk of essential hypertension in a Chinese population.
Abulaiti D et al.
Cardiovascular Diagnosis and Therapy, 2024
Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.
Jasim AA et al.
Frontiers in Genetics, 2018
APOA5 -1131T>C and APOC3 -455T>C polymorphisms are associated with an increased risk of coronary heart disease.
Sun Y et al.
Genetics and Molecular Research : Gmr, 2015
Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.
Domínguez-Reyes T et al.
Lipids in Health and Disease, 2015
Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism.
Kim M et al.
Nutrition Journal, 2014
Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients.
Ouatou S et al.
Lipids in Health and Disease, 2014
Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.
Kang R et al.
Trials, 2014
Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.
Zhou J et al.
Molecular Medicine Reports, 2013
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.
Brautbar A et al.
Journal of Lipid Research, 2013
The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.
Ferreira CN et al.
Gene, 2013
-1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.
Sóter MO et al.
Molecular Biology Reports, 2012
Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M et al.
International Journal of Molecular Medicine, 2012
Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry, 2012
The -1131T>C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines.
Huang MC et al.
The Kaohsiung Journal of Medical Sciences, 2008
Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and -1131C.
Kovář J et al.
Physiological Research, 2008
Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.
Sundl I et al.
Journal of Lipid Research, 2007
Genetic determinants of HDL: monogenic disorders and contributions to variation.
Klos KL et al.
Current Opinion in Cardiology, 2007
A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.
Moreno R et al.
Atherosclerosis, 2006
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
Talmud PJ et al.
Diabetologia, 2006
Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.
Vaessen SF et al.
Journal of Lipid Research, 2006
Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study.
Elosua R et al.
Journal of Lipid Research, 2006
Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.
Hodoglugil U et al.
Journal of Lipid Research, 2006
APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study.
Klos KL et al.
Journal of Lipid Research, 2005
Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
Lai CQ et al.
Journal of Lipid Research, 2004
The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore.
Lai CQ et al.
Journal of Lipid Research, 2003
Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.
Hu M et al.
Journal of Clinical Lipidology, 0
Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY et al.
Journal of Clinical Lipidology, 0